| DOD-ONR | Office of Naval Research | Department of Defense Explosives Ordnance Disposal (EOD) FY20 Science & Technology Program Broad Agency Announcement (BAA) Development of Advanced Technologies for Diagnostic Sensors and Neutralization of Buried & Surface Munitions in Land Environments | N00014-19-S-B003 |
| DOD-ONR-NRL | Naval Research Laboratory | NRL Long Range Broad Agency Announcement (BAA) for Basic and Applied Research | N00173-19-S-BA01 |
| DOE-01 | Headquarters | MINORITY EDUCATION, WORKFORCE, AND TRAINING PROGRAM | DE-FOA-0002042 |
| DOI-FWS | Fish and Wildlife Service | Neotropical Migratory Bird Conservation Act Grants | F19AS00370 |
| DOS-UKR | U.S. Mission to Ukraine | Emerging Donors Challenge Program (EDCP) Round 7 | 01 |
| HHS-HRSA | Health Resources and Services Administration | AIDS Drug Assistance Program (ADAP) Emergency Relief Funds (ERF) | HRSA-20-066 |
| HHS-NIH11 | National Institutes of Health | Trans-Agency Blood-Brain Interface Program (R61/R33 - Clinical Trials Not Allowed) | RFA-HL-20-021 |
| HHS-NIH11 | National Institutes of Health | Myeloid-Derived Suppressor Cells (MDSCs) as Potential Therapeutic Targets in TB/HIV (R01 Clinical Trial Not Allowed) | PAR-19-357 |
| HHS-NIH11 | National Institutes of Health | Myeloid-Derived Suppressor Cells (MDSCs) as Potential Therapeutic Targets in TB/HIV (R21 Clinical Trial Not Allowed) | PAR-19-364 |
| HHS-NIH11 | National Institutes of Health | Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 Clinical Trial Not Allowed) | RFA-HD-20-020 |
| HHS-NIH11 | National Institutes of Health | Planning Grant for Global Infectious Disease Research Training Program (D71 No Clinical Trials Allowed) | PAR-19-362 |
| HHS-NIH11 | National Institutes of Health | Mechanistic Basis of TDP-43-dependent Pathobiology in Common Dementias (R01 Clinical Trial not Allowed) | RFA-NS-20-005 |
| HHS-NIH11 | National Institutes of Health | Peripheral Pathology in the Lewy Body Dementias (R01 Clinical Trial Not Allowed) | RFA-NS-20-014 |
| HHS-NIH11 | National Institutes of Health | Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) | PAR-19-363 |
| HHS-NIH11 | National Institutes of Health | Revision Applications for Mechanisms of Drug Resistance (R01 Clinical Trials Not Allowed) | RFA-CA-19-049 |
| HHS-NIH11 | National Institutes of Health | Revision Applications for Mechanisms of Drug Resistance (P50 Clinical Trials Not Allowed) | RFA-CA-19-053 |
| HHS-NIH11 | National Institutes of Health | Revision Applications for Mechanisms of Drug Resistance (P01 Clinical Trials Not Allowed) | RFA-CA-19-052 |
| HHS-NIH11 | National Institutes of Health | Institutional Research and Academic Career Development Awards (IRACDA) (K12 - Independent Clinical Trial Not Allowed) | PAR-19-366 |
| HHS-NIH11 | National Institutes of Health | Maximizing Investigators' Research Award (R35 - Clinical Trial Optional) | PAR-19-367 |
| HHS-NIH11 | National Institutes of Health | Catalyze: Product Definition Device Prototype Design and Testing, Diagnostic Disease Target Identification and Assay Development, and Research Tool Development (R61/R33 - Clinical Trial Not Allowed) | RFA-HL-20-024 |
| HHS-NIH11 | National Institutes of Health | Catalyze: Product Definition for Small Molecules and Biologics - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed) | RFA-HL-20-023 |
| HHS-NIH11 | National Institutes of Health | Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38) (Clinical Trial Not Allowed) | RFA-HL-20-006 |
| HHS-NIH11 | National Institutes of Health | Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed) | RFA-HL-20-022 |
| HHS-NIH11 | National Institutes of Health | Catalyze: Product Definition Device Prototype Testing and Design Modification, Diagnostic Disease Target Assay Development and Design Characterization, and Research Tool Testing and Validation (R33 - Clinical Trials Not Allowed) | RFA-HL-20-028 |
| HHS-NIH11 | National Institutes of Health | Catalyze: Product Definition for Small Molecules and Biologics - Preliminary Product/Lead Series Identification (R33 - Clinical Trial Not Allowed) | RFA-HL-20-027 |
| HHS-NIH11 | National Institutes of Health | NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed) | PAR-19-370 |
| HHS-NIH11 | National Institutes of Health | Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional) | PAR-19-368 |
| HHS-NIH11 | National Institutes of Health | Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional) | PAR-19-365 |
| HHS-NIH11 | National Institutes of Health | Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed) | PAR-19-369 |
| HHS-NIH11 | National Institutes of Health | NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed) | PAR-19-371 |
| NASA | National Aeronautics and Space Administration | NASA SPACE TECHNOLOGY GRADUATE RESEARCH OPPORTUNITIES - FALL 2020 (NSTGRO20) | 80HQTR19NOA01-20NSTGRO-B4 |
| NSF | National Science Foundation | NSF INCLUDES Planning Grants | 19-600 |
| NSF | National Science Foundation | Oceanographic Facilities and Equipment Support | 19-602 |
| NSF | National Science Foundation | Improving Undergraduate STEM Education: Education and Human Resources | 19-601 |
| USAID | Agency for International Development | People-To-People (P2P) Reconciliation Fund | 7200AA19APS00015 |
Grant Round Up 9/3/19 to 9/9/19
Posted by Customer Service on